Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,158
Closed -$890K 1642
2025
Q4
$890K Buy
+13,158
New +$953K 0.01% 1035
2025
Q3
Sell
-20,761
Closed -$2.13M 1619
2025
Q2
$2.13M Buy
20,761
+18,974
+1,062% +$2.09M 0.02% 727
2025
Q1
$200K Buy
+1,787
New +$199K ﹤0.01% 1297
2024
Q4
Sell
-2,136
Closed -$233K 1608
2024
Q3
$233K Buy
+2,136
New +$214K ﹤0.01% 1424
2023
Q4
Sell
-5,454
Closed -$358K 1557
2023
Q3
$358K Buy
+5,454
New +$376K ﹤0.01% 1363
2023
Q1
Sell
-28,944
Closed -$1.4M 1809
2022
Q4
$1.4M Buy
+28,944
New +$1.44M 0.02% 799
2020
Q3
Sell
-18,558
Closed -$439K 1821
2020
Q2
$439K Buy
+18,558
New +$365K 0.01% 1141

Other funds holding CRVL

Michael Gelband's CRVL Position: Q1 2026 in Review

Michael Gelband sold out of CorVel (CRVL) in Q1 2026, closing a stake of 13,158 shares — an estimated $890K sold.

Michael Gelband first reported a position in CRVL in Q2 2020 and held it in 7 quarters. The position peaked at $2.13M in Q2 2025. 282 funds tracked by Wall St. Rank hold CRVL as of Q1 2026.

  • Michael Gelband reported no remaining CorVel position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 13,158 CorVel shares in Q1 2026, an estimated $890K.
  • Michael Gelband first reported a position in CorVel in Q2 2020 and held it in 7 quarters.
  • Michael Gelband's CorVel position peaked at $2.13M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held CorVel as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.